Cathryn Nagler Lab

Big Brains: Why your gut health is so important, with Cathryn Nagler and Eric Pamer (Ep. 109)

Scientists discuss what we now know about building your microbiome, food allergies and probiotics

5 female-led biotech startups making waves

International Women’s Day takes place on March 8, which celebrates the achievements of women, and also shines a light on gender discrimination and the need to accelerate gender parity. 

Polymers help protect mice from anaphylactic reaction to peanuts, UChicago research finds
Micelle technology is potential platform for treating other allergies, inflammatory gastrointestinal diseases
ClostraBio Announces Breakthrough Publication Describing Targeted Delivery of Metabolite to Gastrointestinal Tract via Oral Nanoparticles; Appoints CEO

ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health.

Prof. Cathryn Nagler honored for outstanding contributions to immunology

UChicago scholar recognized for breakthrough research on microbiome and allergies

Are microbes causing your milk allergy?
Gut Microbes May Be Key to Solving Food Allergies

New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food.

National Geographic: The Microbiome Menagerie

Trillions of microbes call our body home. Now we’re learning they’re crucial for our health.

Can Gut Bacteria Heal Food Allergies?

How manipulating the microbiome could reverse and prevent peanut allergies and more

Could Manipulating the Microbiome Treat Food Allergies?
As evidence grows that gut bacteria play roles in the development and persistence of food allergies, researchers begin to explore microbe-based interventions.
Meet the Polsky Center Startup Taking on Food Allergies
With the help of the Polsky Center, ClostraBio, a company addressing food allergies, was born.
To Better Manage Asthma, Look to the Gut: A Clinical Roundtable
The proliferation of research pertaining to the human gut microbiome has produced numerous findings that point to its role in a range of illnesses, including gastrointestinal, metabolic, and psychiatric diseases. In addition, emerging evidence suggests that the gut microbiome may contribute to the pathogenesis of atopy and asthma.
Clinicians Hopeful About Future Food Allergy Treatments
Food allergies are on the rise. In the U.S., more than 32 million Americans live with the condition. And while food allergies have been well documented in children, a recent study found that 10 percent of adults have a food allergy, and one in four of them developed that allergy as an adult.
Universities Shift to Startup Mode
With big pharma and med-tech companies investing less in nascent technologies, schools hoping to commercialize research help profs launch businesses.
Healthy infants have intestinal bacteria that prevent the development of food allergies, new research shows.
Microbes From Babies' Guts Could Treat a Common Food Allergy
This could be a game-changer.
Are microbes causing your milk allergy?
Millions of Americans suffer from food allergies
Gut Bacteria Protects Against Food Allergies
How gut bacteria from infants could prevent food allergy
Study: Intestinal microbes protect against allergic reaction to cow’s milk
End of an Epidemic. The Nagler Lab is proud to appear in the September 2018 issue of Chicago magazine
The number of people with food allergies has exploded in recent years. A dream team of Chicago researchers and scientists may have figured out why, and now they’re developing therapies that could lead to …
Meet the Crain's Tech 50 of 2018
The founders, leaders, technologists, investors, connectors and mentors you need to know in Chicago tech are all here. There’s one difference this year: They’re all women. Yes, women are underrepresented in tech, in Chicago and beyond. But there are plenty of awesome women to be found. You just have to look. 
UChicago food allergy startup ClostraBio raises $3.5 million
Prof. Cathryn Nagler had been researching the physiological origins of food allergy and potential treatments for over 30 years, but she hadn’t considered the possibility of translating that research into a business. But just 15 months after considering that possibility and beginning her entrepreneurial career, she is the founder of a promising, emerging venture.
This U of C startup thinks it can end food allergies
A biotech startup hopes
Innovation Fund invests $500,000 in microbiome research and energy companies
The University of Chicago Innovation Fund announced plans to invest up to $500,000 into three companies—AVNovum, ClostraBio, and SwitchedSource—that are working in the health and energy fields, respectively.
Sixteen advances in research and innovation in 2016
2016 brought us the launch of several research-based startups, the invention of a new diamond-like coating, the deployment of data-collection nodes across Chicago and a next-generation platform for cancer research. Before getting too deep into the new year, here are 16 highlights in research and innovation at UChicago in 2016:
Choosing Food Allergies. Dr. Cathy Nagler: Gut Check
One name every food allergic person should know is Dr. Cathy Nagler. 
Scientist builds drug development company out of research lab
When Cathryn Nagler set out to develop drugs to treat childhood food allergies, she knew she was heading into unchartered territory. Although Nagler, the Bunning Food Allergy Professor, has been a research scientist for more than 30 years, she had no plans to go into business.
Congratulations to Taylor Feehley on being named one of Forbes “30 under 30”!
Meet The 30 Under 30: Science
Probiotic formula reverses cow’s milk allergies by changing gut bacteria of infants
There has been an unprecedented increase in food allergies in developed countries, rising by as much as 20 percent in the past decade. Allergy to cow’s milk is one of the most common, occurring in up to three percent of children worldwide.
Gut Microbiome: The Peacekeepers
Amid the trillions of microbes that live in the intestines, scientists have found a few species that seem to play a key role in keeping us healthy
Discovery and Impact: The Big Picture for the Microbiome
Every single one of you has 100 trillion bacterial cells on you, and those 100 trillion cells are found all over your body
We are pleased to announce that a FARE-funded researcher, Dr. Cathryn Nagler of the University of Chicago, has received a multi-year, $1.4 million grant from the National Institutes of Health (NIH). Over several years, FARE has provided more than $1.5 million to Dr. Nagler and her team.